ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest leqembi news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks leqembi across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Clinical data presented at AAIC 2026 shows LEQEMBI's subcutaneous autoinjector delivers similar efficacy and safety to the IV formulation for early Alzheimer's disease. The company announcement reports the autoinjector offers a more convenient administration option for patients.
Summaries by ByteBrief